Functional and Epigenomic Consequences of DNMT1 Variants in Inherited Neurological Disorders
Authors:
- Jun-Hui YuanJYJun-Hui Yuan
- Yujiro HiguchiYHYujiro Higuchi
- Masahiro AndoMAMasahiro Ando
- Akiko YoshimuraAYAkiko Yoshimura
- Satoshi NozumaSNSatoshi Nozuma
- Yusuke SakiyamaYSYusuke Sakiyama
- Takashi KandaTKTakashi Kanda
- Masahiro NomotoMNMasahiro Nomoto
- Takeshi NakamuraTNTakeshi Nakamura
- Yasuyuki NobuharaYNYasuyuki Nobuhara
- Hiroshi TakashimaHTHiroshi Takashima
Open Access
- 26 January 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (3) , 1232
Abstract
DNMT1 variants are linked to complex neurodegenerative syndromes, yet their variant-specific functional and epigenomic consequences remain poorly defined. DNMT1 variants were identified in eight patients using gene-panel or whole-exome sequencing. Functional effects were assessed by site-directed mutagenesis and transient expression in HEK293T cells. Genome-wide methylation profiling of peripheral blood leukocyte DNA was performed using Nanopore sequencing, enabling direct quantification of 5-methylcytosine (5mC). CpG island-level differential methylation and gene set enrichment analysis (GSEA) were conducted. Variants in the replication foci targeting sequence (RFTS) domain (p.Y511H, p.Y540C, p.H569R) exhibited reduced DNMT1 protein expression, decreased enzymatic activity, and cytosolic aggregation. Variants in the C-terminal catalytic domain (p.A1334V and p.P1546S) showed reduced protein expression with relatively mild enzymatic impairment. Patients carrying the p.Y511H variant demonstrated a significant reduction in global 5mC levels compared with controls. Principal component analysis revealed distinct methylomic profiles separating most patients from controls, with marked intra- and inter-familial heterogeneity. CpG island-level analysis identified a single significantly hypomethylated region in p.Y511H carriers, and GSEA revealed differential enrichment of multiple Gene Ontology biological pathways. This study defines domain-dependent functional effects of DNMT1 variants and provides the first nanopore-based methylome analysis, revealing variant-specific and heterogeneous epigenomic alterations.Keywords
Funding Information
- Ministry of Health, Labour and Welfare (20317603, 201610002B)
- Japan Agency for Medical Research and Development (201442014A, 201442071A)
- Japan Society for the Promotion of Science (JP18H02742, JP20K16604, JP21K15702, JP21H02842, JP22K15713, JP22K07495, JP22K07519)
This publication has 30 references indexed in Scilit:
- Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseasesGenetics in Medicine, 2024
- Structural basis for activation of DNMT1Nature Communications, 2022
- Systematic benchmarking of tools for CpG methylation detection from nanopore sequencingNature Communications, 2021
- Evaluation of DNA Methylation Episignatures for Diagnosis and Phenotype Correlations in 42 Mendelian Neurodevelopmental DisordersThe American Journal of Human Genetics, 2020
- Intragenic DNA methylation prevents spurious transcription initiationNature, 2017
- Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing lossNature Genetics, 2011
- Rethinking how DNA methylation patterns are maintainedNature Reviews Genetics, 2009
- Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanismNature, 2008
- The repertoire of solute carriers of family 6: Identification of new human and rodent genesBiochemical and Biophysical Research Communications, 2005
- A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nucleiCell, 1992